NasdaqGS - Nasdaq Real Time Price USD
Revolution Medicines, Inc. (RVMDW)
0.0870
+0.0050
+(6.10%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-557,436
-557,436
-350,572
-224,401
-147,180
Investing Cash Flow
-554,394
-554,394
-342,598
-24,116
-142,117
Financing Cash Flow
959,413
959,413
1,229,200
301,432
294,179
End Cash Position
546,762
546,762
699,179
163,149
110,234
Capital Expenditure
-10,308
-10,308
-7,729
-10,816
-6,528
Issuance of Capital Stock
846,348
846,348
385,759
298,045
291,241
Free Cash Flow
-567,744
-567,744
-358,301
-235,217
-153,708
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLDWW Calidi Biotherapeutics, Inc.
0.0055
-15.38%
APLMW Apollomics, Inc.
0.0078
-18.75%
DNABW Ginkgo Bioworks Holdings, Inc.
0.0071
-4.05%
VIRX Viracta Therapeutics, Inc.
0.0173
+1.76%
PHRM.CN PharmaTher Holdings Ltd.
0.1850
+2.78%
MDNAF Medicenna Therapeutics Corp.
0.7590
-0.78%
PTGX Protagonist Therapeutics, Inc.
46.16
+0.68%
BPMC Blueprint Medicines Corporation
85.81
+2.88%
ALEC Alector, Inc.
1.1600
+4.50%
PYXS Pyxis Oncology, Inc.
1.0800
+5.88%